BALYASNY ASSET MANAGEMENT L.P. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 299 filers reported holding HAEMONETICS CORP in Q2 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2024$7,739,026
+97.0%
90,674
+97.3%
0.01%
+100.0%
Q4 2023$3,928,843
-15.7%
45,946
-16.1%
0.01%
-30.0%
Q2 2023$4,659,968
-63.2%
54,733
-64.2%
0.01%
-68.8%
Q1 2023$12,657,606
-29.8%
152,962
-37.2%
0.03%
-41.8%
Q3 2022$18,039,000
-49.4%
243,677
-55.4%
0.06%
-52.6%
Q2 2022$35,632,000
+89.2%
546,676
+53.9%
0.12%
+81.2%
Q4 2021$18,836,000
-21.7%
355,127
+4.2%
0.06%
-36.0%
Q3 2021$24,058,000
+2873.8%
340,816
+2708.8%
0.10%
+2400.0%
Q2 2021$809,000
-95.9%
12,134
-92.6%
0.00%
-96.3%
Q4 2020$19,587,000
-14.3%
164,944
-37.0%
0.11%
-35.1%
Q3 2020$22,861,000
+101.9%
262,020
+107.3%
0.17%
+71.4%
Q2 2020$11,323,000
-43.7%
126,424
-27.8%
0.10%
-18.3%
Q4 2019$20,121,000
+2499.6%
175,119
+1879.6%
0.12%
+2300.0%
Q1 2019$774,000
+74.3%
8,846
+78.6%
0.01%
+150.0%
Q2 2018$444,000
+28.0%
4,953
-35.9%
0.00%
+100.0%
Q3 2017$347,000
-86.7%
7,730
-88.3%
0.00%
-90.9%
Q2 2017$2,618,00066,3000.01%
Other shareholders
HAEMONETICS CORP shareholders Q2 2023
NameSharesValueWeighting ↓
Bridge City Capital, LLC 40,541$5,114,0002.20%
Lisanti Capital Growth, LLC 53,385$6,734,0002.20%
Nitorum Capital, L.P. 279,510$35,257,0002.05%
CROWN ADVISORS MANAGEMENT, INC. 20,000$2,523,0001.69%
Millrace Asset Group, Inc. 11,400$1,438,0001.69%
COOKSON PEIRCE & CO INC 145,884$18,402,0001.61%
Endurant Capital Management LP 32,594$4,111,0001.48%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 111,000$14,002,0001.38%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 110,065$13,884,0001.37%
EMERALD ADVISERS, LLC 203,640$25,687,0001.20%
View complete list of HAEMONETICS CORP shareholders